Włodzimierz Mazur

Adding pegylated interferon to entecavir for hepatitis B e antigen–positive chronic hepatitis B: A multicenter randomized trial (ARES study)

Willem Pieter Brouwer, Qing Xie, Milan J. Sonneveld et al. · Hepatology · 2014 · 165 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Chemerin, vaspin and insulin resistance in chronic hepatitis C

Michał Kukla, K Zwirska-Korczala, Andrzej Gabriel et al. · Journal of Viral Hepatitis · 2009 · 70 citations

Medicine, Endocrinology, Immunology +15

Quantification of HBsAg in nucleos(t)ide-naïve patients treated for chronic hepatitis B with entecavir with or without tenofovir in the BE-LOW study

Fabien Zoulim, Giampiero Carosi, Susan Greenbloom et al. · Journal of Hepatology · 2014 · 69 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials

Gregory J. Dore, Brian Conway, Yan Luo et al. · Journal of Hepatology · 2015 · 68 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Liver visfatin expression in morbidly obese patients with nonalcoholic fatty liver disease undergoing bariatric surgery.

Michał Kukla, Monika Ciupińska-Kajor, Maciej Kajor et al. · PubMed · 2010 · 53 citations

Medicine, Immunology, Pathology +17